Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 381 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/09/20
End: 01/28/21
Due: 01/28/22
Phase: N/A
Priority: Normal
Start: 08/09/23
End: 09/30/26
Due: 09/30/27
UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 03/31/05
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 10/03/23
End: 05/30/24
Due: 05/30/25
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 04/05/22
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 11/01/18
End: 09/02/21
Due: 09/02/22
Phase: N/A
Priority: Normal
Start: 10/13/23
End: 08/17/24
Due: 08/17/25
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 01/31/27
Due: 01/31/28
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 10/01/17
End: 01/24/19
Due: 01/24/20
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 05/19/16
Due: 05/19/17
Phase: N/A
Priority: Normal
Start: 01/01/12
End: 02/28/26
Due: 02/28/27